questionnaires
OtherQuestionnaire for patient: satisfaction regarding rechargeable DBS battery Questionnaire for neurologist: seizure frequency, satisfaction regarding rechargeable DBS battery
NCT Number: NCT03404128
Follow up of the patients at Ghent University Hospital treated with hippocampal DBS for refractory epilepsy.
Endpoints:
* Long term evaluation of the effects of hippocampal DBS on seizure frequency and cognition * Evaluation of the satisfaction of patients and neurologist regarding the rechargeable DBS battery
Looking for future studies?
Notify MeAll sexes
Observational
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Questionnaire for patient: satisfaction regarding rechargeable DBS battery Questionnaire for neurologist: seizure frequency, satisfaction regarding rechargeable DBS battery
Time frame: Every six months (up to 2 years after implantation of rechargeable device)
Efficacy measured by reduction in seizure frequency before and after implantation
Time frame: Yearly (up to 2 years after implantation of rechargeable device)
Cognition measured by neuropsychological testing
Time frame: Every six months (up to 2 years after implantation of rechargeable device)
Reporting of device problems including long charging time, bad connection between device and charger, high frequency of charging (> 1 time a day).
Time frame: Every six months (up to 2 years after implantation of rechargeable device)
Reporting of adverse events after implantation
University Hospital, Ghent
Other
Long Term Follow-up of Patients Treated With Hippocampal Deep Brain Stimulation for Refractory Epilepsy
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06387186
Brain Diseases, Central Nervous System Diseases
Boston, Massachusetts, United States
View Trial DetailsNCT06141668
Brain Diseases, Central Nervous System Diseases
Boston, Massachusetts, United States
View Trial DetailsNCT04770337
Brain Diseases, Central Nervous System Diseases
Phoenix, Arizona, United States
View Trial DetailsNCT05292183
Brain Diseases, Central Nervous System Diseases
Lebanon, New Hampshire, United States
View Trial Details